Micafungin Salvage Mono-therapy in Invasive Aspergillosis

Clinical trial NCT00376337 · TERMINATED

Trial details

NCT number: NCT00376337
Sponsor: Astellas Pharma Inc
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Invasive Aspergillosis

Start date: 2006-06-01
Primary completion: 2008-09-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.